Amedisys Inc (AMED)

Working capital turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	2,236,382	2,227,658	2,229,409	2,234,331	2,223,199	1,671,704	1,667,201	1,111,979	573,337	567,158	15,793	33,153	518,223	1,014,511	1,507,022	1,979,978	1,955,633	1,889,333	1,810,011	1,726,487
Total current assets	US$ in thousands	496,935	467,227	426,544	405,557	388,961	388,780	394,869	392,485	356,684	432,882	390,965	380,450	361,984	411,250	449,540	468,128	350,554	299,519	275,785	271,731
Total current liabilities	US$ in thousands	473,721	468,119	462,401	353,050	355,529	367,200	427,372	380,154	374,282	454,349	449,223	456,082	456,337	437,496	442,048	316,106	326,943	314,653	313,007	297,377
Working capital turnover		96.34	—	—	42.55	66.50	77.47	—	90.18	—	—	—	—	—	—	201.15	13.02	82.83	—	—	—

December 31, 2023 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $2,236,382K ÷ ($496,935K – $473,721K)
= 96.34

The working capital turnover ratio of Amedisys Inc. fluctuated over the past eight quarters, ranging from a low of 42.55 in Q1 2023 to a high of 180.21 in Q1 2022. This ratio measures the efficiency with which the company utilizes its working capital to generate revenue, with a higher ratio indicating better efficiency.

In Q4 2022, the ratio was 66.50, indicating that for every $1 of working capital, the company generated $66.50 of revenue. This ratio increased to 102.89 in Q3 2022, reflecting improved working capital efficiency. However, in Q4 2023, the ratio significantly rose to 96.34, suggesting a potential decline in efficiency compared to the previous quarters.

The absence of data for Q3 2023 and Q2 2023 limits a comprehensive trend analysis. It is important to monitor future quarters to assess the consistency and sustainability of Amedisys Inc.'s working capital management efficiency.